Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ling Li, Yudan Chen & Chang Shi. (2022) Nintedanib ameliorates oxidized low-density lipoprotein -induced inflammation and cellular senescence in vascular endothelial cells. Bioengineered 13:3, pages 6196-6207.
Read now
Read now
Articles from other publishers (4)
Jia He, Shuang Xu, Mingzhu Jiang, Ting Wang, Yue Zhang, Zhanjun Jia, Mi Bai & Aihua Zhang. (2023) CDC20 inhibition alleviates fibrotic response of renal tubular epithelial cells and fibroblasts by regulating nuclear translocation of β-catenin. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1869:4, pages 166663.
Crossref
Crossref
Ji Wang, Zongyu Xiao, Peng Li, Chunwang Wu, Yan Li, Qing Wang, Yanming Chen, Honglong Zhou, Zhi Li, Zhaotao Wang, Qing Lan & Yezhong Wang. (2023) PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1B. Oncogene 42:14, pages 1088-1100.
Crossref
Crossref
Katie Joanna Miller, Isla Henry, Zoe Maylin, Christopher Smith, Einthavy Arunachalam, Hardev Pandha & Mohammad Asim. (2023) A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer. Frontiers in Oncology 13.
Crossref
Crossref
Chaeyeong Kim, Gyeyeong Kong, Hyunji Lee, Quangdon Tran, Thuy-Trang T. Vo, So Hee Kwon, Jisoo Park, Seon-Hwan Kim & Jongsun Park. (2022) Scavenger receptor class F member 2 (SCARF2) as a novel therapeutic target in glioblastoma. Toxicological Research 38:2, pages 249-256.
Crossref
Crossref